论文部分内容阅读
作者报道静脉应用榄香烯乳注射液治疗中晚期肺癌。全组53例，近期有效率为32．1％，生活质量改善率54．7％，其中原发。性肺癌组46例，两率分别为34．8％和56．5％；转移性肺癌组7例，两率分别为14．3％和42．9％。该药毒副反应少，常见为轻中度药物热和科脉炎，可对症防治。结果表明，榄香烯乳是治疗肺癌的一种新的有效药物。
The authors reported intravenous elemene emulsion injection for the treatment of advanced lung cancer. In the whole group of 53 cases, the recent effective rate was 32.1%, and the quality of life improvement rate was 54.7%, of which the primary was. In the 46 patients with lung cancer, the two rates were 34.8% and 56.5%, respectively; in the metastatic lung cancer group, there were 7 patients, and the two rates were 14.3% and 42.9%, respectively. The side effects of this drug are few, usually mild to moderate drug fever and branch vein inflammation, symptomatic control. The results showed that elemene milk is a new effective drug for the treatment of lung cancer.